Reversing Therapy Resistance With Epigenetic-Immune Modification
Clinical trial NCT02395627 · TERMINATED
Trial details
- NCT number
- NCT02395627
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-04
- Primary completion
- 2019-06-08
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.